Drug Shortage Report for LOSARTAN HCT

Last updated on 2021-03-23 History
Report ID 120609
Drug Identification Number 02388987
Brand name LOSARTAN HCT
Common or Proper name LOSARTAN HCT
Company Name SIVEM PHARMACEUTICALS ULC
Market Status DORMANT
Active Ingredient(s) LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE
Strength(s) 100MG 25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-03-15
Actual start date
Estimated end date 2021-04-05
Actual end date 2021-03-22
Shortage status Resolved
Updated date 2021-03-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2021-03-23 French Compare
v21 2021-03-23 English Compare
v20 2021-03-16 English Compare
v19 2021-02-16 French Compare
v18 2021-02-16 English Compare
v17 2021-02-16 English Compare
v16 2021-01-26 French Compare
v15 2021-01-26 English Compare
v14 2021-01-26 English Compare
v13 2020-12-23 French Compare
v12 2020-12-23 English Compare
v11 2020-12-22 English Compare
v10 2020-12-03 French Compare
v9 2020-12-03 English Compare
v8 2020-12-01 English Compare
v7 2020-11-13 French Compare
v6 2020-11-13 English Compare
v5 2020-10-27 English Compare
v4 2020-08-04 French Compare
v3 2020-08-04 English Compare

Showing 1 to 20 of 22